Enable job alerts via email!
A leading pharmaceutical company in Liverpool seeks a Manager, Finance Business Partner to provide financial insights and support operations. The ideal candidate should possess a degree in Accounting or Finance, have significant industry experience, and demonstrate strong analytical and leadership skills. This hybrid role requires collaboration across teams and ensures adherence to financial controls and policies.
The Opportunity: Manager, Finance Business Partner, Fixed-Term Contract
Reporting to the Finance Director/Lead Finance Business Partner in Liverpool, you will provide finance business partner support to operations and quality functions on site. You will provide financial insights to support decision making to meet local operational demands and drive improved efficiencies.
You will also be the primary finance business partner to the Local Project Management Office (PMO) and the Site Investment Review Board (SIRB). You will partner with the business to prioritize projects and set financial budgets and forecasts, ensuring financial risks are appropriately identified and managed, and ensure financial performance is tracked and fully understood. You will assist with preparation of Business Cases, including cost estimates and ROI calculations, and support the development of financial models for project evaluation and conduct scenario analysis to assess financial implications of various project outcomes.
To be successful in this role, you will be required to possess a combination of financial expertise, industry knowledge, strategic thinking, and leadership skills.
The role is based in Speke, Liverpool
Hybrid role: Office based 3-days a week
CSL Seqirus is committed to attracting and retaining world-class employees who are valued for their contributions to achieving business objectives. Learn more about some of the benefits you can participate in when you join CSL Seqirus.
CSL Seqirus is part of CSL. As one of the largest influenza vaccine providers in the world, CSL Seqirus is a major contributor to the prevention of influenza globally and a transcontinental partner in pandemic preparedness. With state-of-the-art production facilities in the U.S., the U.K. and Australia, CSL Seqirus utilizes egg, cell and adjuvant technologies to offer a broad portfolio of differentiated influenza vaccines in more than 20 countries around the world.
At CSL, Inclusion and Belonging is at the core of our mission and who we are. It fuels our innovation day in and day out. By celebrating our differences and creating a culture of curiosity and empathy, we are able to better understand and connect with our patients and donors, foster strong relationships with our stakeholders, and sustain a diverse workforce that will move our company and industry into the future. Learn more Inclusion and Belonging | CSL.
Watch our \"On the Front Line\" video to learn more about CSL Seqirus